Aquinox Pharmaceuticals, Inc.https://pcaobus.org/form-ap-filings/38837/38837Aquinox Pharmaceuticals, Inc.388374/11/2019 6:01:58 PM2018ba5e4677-f4de-4594-bf59-13c208aaaa901208Deloitte LLP (French Translation: Deloitte S.E.N.C.R.L./s.r.l.)392950Aquinox Pharmaceuticals, Inc.1404644NLTX0120864656Beverley Grace Pao0120864656True
Aquinox Pharmaceuticals, Inc.https://pcaobus.org/form-ap-filings/22218/22218Aquinox Pharmaceuticals, Inc.222184/10/2018 1:30:39 PM20174631c8eb-bb41-403c-afca-31503c8a275a1208Deloitte LLP (French Translation: Deloitte S.E.N.C.R.L./s.r.l.)392950Aquinox Pharmaceuticals, Inc.1404644NLTX0120864656Beverley Grace Pao0120864656True
Novelion Therapeutics Inc.https://pcaobus.org/form-ap-filings/6270/6270Novelion Therapeutics Inc.62704/18/2017 9:01:17 AM201601628220-4cf8-46b2-8bff-b2ff1edb44b91208Deloitte LLP (French Translation: Deloitte S.E.N.C.R.L./s.r.l.)33620Novelion Therapeutics Inc.827809NVLNF; NVLN.0120864656Beverley Grace Pao0120864656True
Aquinox Pharmaceuticals, Inc.https://pcaobus.org/form-ap-filings/4114/4114Aquinox Pharmaceuticals, Inc.41143/27/2017 1:45:46 PM20167ef6b71f-c322-472a-9e15-77d6c91670fa1208Deloitte LLP (French Translation: Deloitte S.E.N.C.R.L./s.r.l.)392950Aquinox Pharmaceuticals, Inc.1404644NLTX0120864656Beverley Grace Pao0120864656True